- Companies
- Yuyu Pharma
Yuyu Pharma Valuation Multiples
Yuyu Pharma is valued at $44M as of November 2026, a 0.5x revenue multiple. In the last fiscal year, Yuyu Pharma revenue was $106M and Yuyu Pharma EBITDA was $13M.
Yuyu Pharma Overview
About Yuyu Pharma
Yuyu Pharma Inc. manufactures and markets medicines. The product is the medicines for Alzheimer's, which accounts for 45% of total revenue. The company also engages in health aid foods, rental of oxygen generator and analysis of medicines.
Founded
1941
HQ
Employees
N/A
Website
Sectors
Financials (Last FY)
EV
$55M
Valuation Multiples
Start free trialYuyu Pharma Financials
Yuyu Pharma reported last fiscal year revenue of $106M and EBITDA of $13M.
In the same fiscal year, Yuyu Pharma generated $40M in gross profit, $13M in EBITDA, and $6M in net income.
Yuyu Pharma P&L
In the most recent fiscal year, Yuyu Pharma reported revenue of $106M and EBITDA of $13M.
Yuyu Pharma is profitable as of last fiscal year, with gross margin of 38%, EBITDA margin of 12%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Yuyu Pharma Stock Performance
Yuyu Pharma has current market cap of $44M, and enterprise value of $55M.
Market Cap Evolution
Yuyu Pharma's stock price is $2.79.
Yuyu Pharma has an EPS (earnings per share) of $0.39.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $55M | $44M | 0.7% | - | - | - | $0.39 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialYuyu Pharma Valuation Multiples
Yuyu Pharma trades at 0.5x EV/Revenue multiple, and 4.3x EV/EBITDA.
Yuyu Pharma Financial Valuation Multiples
As of November 19, 2026, Yuyu Pharma has market cap of $44M and EV of $55M.
Yuyu Pharma has a P/E ratio of 7.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Yuyu Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Yuyu Pharma Margins & Growth Rates
In the most recent fiscal year, Yuyu Pharma reported gross margin of 38%, EBITDA margin of 12%, and net margin of 6%.
Yuyu Pharma Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Yuyu Pharma Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Yuyu Pharma Competitors
Yuyu Pharma competitors include J. Molner, OSE Immunotherapeutics, Semnur Pharmaceuticals, Labiana Health, Shield Therapeutics, Elicio Therapeutics, Prescient Therapeutics, Oncoinvent, Intercure and Sangamo Therapeutics.
Most Yuyu Pharma public comparables operate across Biopharmaceuticals.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1M | $960K | 39.7x | - | 52.2x | - | |||
| $3M | ($35M) | 20.3x | 7.5x | (1.7x) | (1.8x) | |||
| - | ($160M) | - | - | (0.4x) | - | |||
| $83M | $12M | 0.9x | 0.9x | 6.5x | 6.1x | |||
| $50M | ($9M) | 1.3x | 1.1x | (7.2x) | (22.4x) | |||
| - | ($38M) | - | - | (0.7x) | - | |||
| - | - | - | - | - | - | |||
| $2M | ($15M) | 14.4x | 17.0x | (2.3x) | (2.3x) | |||
This data is available for Pro users. Sign up to see all Yuyu Pharma competitors and their valuation data. Start Free Trial | ||||||||
Investments by Yuyu Pharma
Yuyu Pharma has invested in 2 companies to date.
Latest investment by Yuyu Pharma was on February 4th 2026. Yuyu Pharma invested in James & Ella in their Strategic investment round.
Latest Investments by Yuyu Pharma
| Description | James & Ella produces freeze-dried, shelf-stable raw meals revolutionizing convenient pet nutrition. | Dalan Animal Health is an Athens, Georgia-headquartered biotechnology firm developing RNA interference vaccines against American foulbrood and other bee pathogens. Founded in 2018, the platform targets commercial beekeepers to protect pollination-dependent agriculture. |
| HQ Country | ||
| HQ City | London | Athens, GA |
| Deal Date | 4 Feb 2026 | 2 Dec 2025 |
| Round | Strategic investment | Undisclosed stage |
| Raised | undisclosed | undisclosed |
| Investors | Yuyu Pharma | Yuyu Pharma |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Yuyu Pharma investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Yuyu Pharma
| When was Yuyu Pharma founded? | Yuyu Pharma was founded in 1941. |
| Where is Yuyu Pharma headquartered? | Yuyu Pharma is headquartered in South Korea. |
| Is Yuyu Pharma publicly listed? | Yes, Yuyu Pharma is a public company listed on Korea Exchange. |
| What is the stock symbol of Yuyu Pharma? | Yuyu Pharma trades under 000220 ticker. |
| When did Yuyu Pharma go public? | Yuyu Pharma went public in 1975. |
| Who are competitors of Yuyu Pharma? | Yuyu Pharma main competitors include J. Molner, OSE Immunotherapeutics, Semnur Pharmaceuticals, Labiana Health, Shield Therapeutics, Elicio Therapeutics, Prescient Therapeutics, Oncoinvent, Intercure, Sangamo Therapeutics. |
| What is the current market cap of Yuyu Pharma? | Yuyu Pharma's current market cap is $44M. |
| What is the current revenue of Yuyu Pharma? | Yuyu Pharma's last fiscal year revenue is $106M. |
| What is the current EV/Revenue multiple of Yuyu Pharma? | Current revenue multiple of Yuyu Pharma is 0.5x. |
| Is Yuyu Pharma profitable? | No, Yuyu Pharma is not profitable. |
| How many companies Yuyu Pharma has acquired to date? | Yuyu Pharma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Yuyu Pharma has invested to date? | As of November 2026, Yuyu Pharma has invested in 2 companies. |
| What was the last Yuyu Pharma investment? | On 4th February 2026 Yuyu Pharma invested in James & Ella, participating in a Strategic investment round. |
| In what companies Yuyu Pharma invested in? | Yuyu Pharma invested in James & Ella and Dalan Animal Health. |
See public comps similar to Yuyu Pharma
Lists including Yuyu Pharma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




